Export

Institut Produits Synthése (IPSEN) AB

Financial information

The information source is the annual report of the company with business id 556701-3106

* Closing information (×1000) SEK

Fiscal year 202312 202212
Number of months: 12 12
Turnover: 764,268 Revenue Up 715,672 Revenue Down
Financial expenses: 106 Revenue Down 735 Revenue Down
Earnings before taxes: 36,697 Revenue Up 17,363 Revenue Down
Total assets: 421,639 Revenue Up 399,724 Revenue Down
Current assets: 419,401 Revenue Up 397,026 Revenue Down
Current liabilities: 197,415 Revenue Down 204,064 Revenue Down
Equity capital: 224,224 Revenue Up 195,660 Revenue Up
Share capital: 14,000 14,000
Number of employees: 54 Revenue Up 53 Revenue Up

Financial ratios

Solvency: 53.2% Revenue Up 48.9% Revenue Up
Turnover per employee: 14,153 Revenue Up 13,503 Revenue Down
Profitability: 4.8% Revenue Up 2.4% Revenue Down
Return on equity (ROE): 16.4% Revenue Up 8.9% Revenue Down
Current ratio: 212.4% Revenue Up 194.6% Revenue Up
Return on assets (ROA): 8.7% Revenue Up 4.5% Revenue Down

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202312
Number of months: 12
Turnover: 764,268
Financial expenses: 106
Earnings before taxes: 36,697
Total assets: 421,639
Current assets: 419,401
Current liabilities: 197,415
Equity capital: 224,224
Share capital: 14,000
Number of employees: 54

Financial ratios

Solvency: 53.2%
Turnover per employee: 14,153
Profitability: 4.8%
Return on equity (ROE): 16.4%
Current ratio: 212.4%
Return on assets (ROA): 8.7%